These findings strongly suggest that RBPJ functions as a crucial TF for ORC6, and the increased binding between the RBPJ protein and the ORC6 promoter region could potentially be a pivotal mechanism of ORC6 overexpression in glioma. The gene discussed is ORC6; the disease is central nervous system cancer.